1. Home
  2. MEOH vs SUPN Comparison

MEOH vs SUPN Comparison

Compare MEOH & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methanex Corporation

MEOH

Methanex Corporation

HOLD

Current Price

$48.75

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.84

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEOH
SUPN
Founded
1968
2005
Country
Canada
United States
Employees
1415
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
2.8B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
MEOH
SUPN
Price
$48.75
$50.84
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$48.67
$61.60
AVG Volume (30 Days)
592.1K
716.9K
Earning Date
03-05-2026
02-24-2026
Dividend Yield
1.52%
N/A
EPS Growth
40.35
N/A
EPS
2.98
N/A
Revenue
$3,569,374,000.00
$681,539,000.00
Revenue This Year
$1.99
$8.18
Revenue Next Year
$12.55
$22.15
P/E Ratio
$17.66
N/A
Revenue Growth
N/A
4.54
52 Week Low
$25.46
$29.16
52 Week High
$51.94
$57.65

Technical Indicators

Market Signals
Indicator
MEOH
SUPN
Relative Strength Index (RSI) 53.65 49.96
Support Level $46.66 $49.76
Resistance Level $50.37 $51.99
Average True Range (ATR) 1.78 1.40
MACD -0.34 0.08
Stochastic Oscillator 23.85 54.04

Price Performance

Historical Comparison
MEOH
SUPN

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: